| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 556.58 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Over the past two decades, high flow nasal cannula (HFNC) has emerged as a home treatment for patients with chronic respiratory diseases and chronic respiratory failure. This therapy provides heated and humidified gas admixture at a high flow rate (up to 60 L/min) via a wide-bore nasal cannula and its key benefits include its ability to deliver precise oxygen concentrations and reduce work of breathing.1 It serves as an alternative to traditional home respiratory treatments by improving oxygenation, enhancing carbon dioxide clearance and promoting mucociliary clearance.
Description
© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4. 0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent
Keywords
High flow nasal cannula (HFNC) Home care Interstitial lung disease Neoplasy Non-invasive ventilation (NIV)
Pedagogical Context
Citation
Pulmonology. 2025 Dec 31;31(1):2423556
Publisher
Taylor & Francis